Advances in clinical researches on cerebrovascular diseases in 2015

doi:10.3969/j.issn.1004-583X.2016.02.001

Abstract

Abstract: Many substantial advances have been made in the clinical researches on cerebrovascular diseases in 2015. The article reviews the following new advancements in endovascular treatment of acute ischemic stroke, stenting for symptomatic intracranial artery stenosis, new thrombolytic agents, neuroprotectants, folic acid therapy in primary prevention of stroke, treatment for cervical artery dissection, guidelines on cerebrovascular diseases, and development of the construction of stroke in China.

Key words: stroke, advances, review

CLC Number:

R743

Zhang Yusheng, Chen Yunyu, Chen Danxia, Dong Dawei, Mai Hongcheng, Xu Anding. Advances in clinical researches on cerebrovascular diseases in 2015[J]. Clinical Focus, 2016, 31(2): 117-122.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.02.001

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I2/117

References

[1] Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke[J]. N Engl J Med, 2013, 368(10): 914-923.
[2] Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke[J]. N Engl J Med, 2013, 368(10):904-913.
[3] Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke[J]. N Engl J Med, 2013, 368(10):893-903.
[4] Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke[J]. N Engl J Med, 2015, 372(1):11-20.
[5] Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection[J]. N Engl J Med, 2015, 372(11):1009-1018.
[6] Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke[J]. N Engl J Med, 2015, 372 (11): 1019-1030.
[7] Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke[J]. N Engl J Med, 2015, 372(24): 2285-2295.
[8] Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke[J]. N Engl J Med, 2015, 372(24):2296-2306.
[9] 中国卒中学会, 中国卒中学会神经介入分会, 中华预防医学会卒中预防与控制专业委员会介入学组. 急性缺血性卒中血管内治疗中国指南2015[J]. 中国卒中杂志, 2015, 10(7):590-606.
[10] Powers WJ, Derdeyn CP, Biller J, et al. 2015 American Heart Association/ American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2015, 46(10):3020-3035.
[11] Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect of a balloon- expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial[J]. JAMA, 2015, 313(12):1240-1248.
[12] Compter A, van der Worp HB, Schonewille WJ, et al. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial[J]. Lancet Neurol, 2015, 14(6):606-614.
[13] Miao Z, Zhang Y, Shuai J, et al. Thirty-day outcome of a multicenter registry study of stenting for symptomatic intracranial artery stenosis in China[J]. Stroke, 2015,46(10):2822-2829.
[14] Huang X, Cheripelli BK, Lloyd SM, et al. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study[J]. Lancet Neurol, 2015, 14(4):368-376.
[15] Coutts SB, Dubuc V, Mandzia J, et al. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion[J]. Stroke, 2015, 46(3):769-774.
[16] Albers GW, von Kummer R, Truelsen T, et al. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial[J]. Lancet Neurol, 2015, 14(6): 575-584.
[17] Saver JL, Starkman S, Eckstein M, et al. Prehospital use of magnesium sulfate as neuroprotection in acute stroke[J]. N Engl J Med, 2015, 372(6):528-536.
[18] 胡大一, 徐希平. 有效控制“H型”高血压预防卒中的新思路[J]. 中华内科杂志, 2008, 47(12):976-977.
[19] Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial[J]. JAMA, 2015, 313(13):1325-1335.
[20] CADISS trial investigators, Markus HS, Hayter E, et al. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial[J]. Lancet Neurol, 2015, 14(4):361-367.
[21] Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2015, 46(7):2032-2060.
[22] Torbey MT, B sel J, Rhoney DH, et al. Evidence-based guidelines for the management of large hemispheric infarction: a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine[J]. Neurocrit Care, 2015, 22(1):146-164.
[23] Smith CJ, Kishore AK, Vail A, et al. Diagnosis of stroke-associated pneumonia: recommendations from the pneumonia in stroke consensus group[J]. Stroke, 2015, 46(8):2335-2340.
[24] Harris D, Hall C, Lobay K, et al. Canadian Association of Emergency Physicians position statement on acute ischemic stroke[J]. CJEM, 2015, 17(2):217-226.
[25] Eskes GA, Lanct t KL, Herrmann N, et al. Canadian stroke best practice recommendations: mood, aognition and fatigue following stroke practice guidelines, update 2015[J]. Int J Stroke, 2015, 10(7):1130-1140.
[26] Jung KH, Yu KH, Kim YD, et al. Antithrombotic management of patients with nonvalvular atrial fibrillation and ischemic stroke or transient ischemic attack: executive summary of the Korean clinical practice guidelines for stroke[J]. J Stroke, 2015, 17(2):210-215.
[27] Middleton S, Grimley R, Alexandrov AW. Triage, treatment, and transfer: evidence-based clinical practice recommendations and models of nursing care for the first 72 hours of admission to hospital for acute stroke[J]. Stroke, 2015, 46(2):e18-25.
[28] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志, 2015, 48(4):246-257.
[29] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014[J]. 中华神经科杂志, 2015, 48(4):258-273.
[30] 中华医学会神经病学分会, 中华医学会神经病学分会神经血管介入协作组,急性缺血性脑卒中介入诊疗指南撰写组. 中国急性缺血性脑卒中早期血管内介入诊疗指南[J]. 中华神经科杂志, 2015, 48(5):356-361.
[31] 国家卫生和计划生育委员会, 神经内科医疗质量控制中心. 中国卒中中心建设指南[J]. 中国卒中杂志, 2015, 10(6):499-507.
[32] 中华预防医学会卒中预防与控制专业委员会介入学组. 缺血性脑血管病介入治疗抗血小板策略中国专家共识[J]. 中华医学杂志, 2015, 95(11):803-809.
[33] 中华预防医学会卒中预防与控制专业委员会脑血管病介入学组. 症状性动脉粥样硬化性椎动脉起始部狭窄血管内治疗中国专家共识[J]. 中华医学杂志, 2015, 95(9):648-653.